Search Results
Results found for "Glaxo Inc"
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
These tools are fully open to academic researchers , with wide applicability beyond just RAMPs — including As the field advances, the computational layer — including AlphaFold and structural prediction tools — will play an increasingly pivotal role. Outside of the lab, Ilana is a leader within her community, spearheading several outreach initiatives including
- GPCR University | Dr. GPCR Ecosystem
Community forum & ecosystem access Intelligence Hub dashboard Grandfather guarantee — your rate never increases Masterclasses cover a variety of track including but not limited to pharmacology foundations, agonists Grandfather guarantee: your rate never increases. No surprise charges.
- About Dr. GPCR Ecosystem | Uniting the GPCR Community to Advance Drug Discovery
Who Should Join To join the community, you should be actively related to the GPCR field , including: Evidence first; hype last Openness with Intent — Share to accelerate; respect boundaries Diversity & Inclusion
- Content and Conduct Policy | Dr. GPCR Ecosystem
After we are notified of a potential policy violation, we may review the content and take action, including You assume all risks associated with Your Content, including anyone's reliance on its quality, accuracy publicly displaying it, reformatting it, incorporating it into advertisements and other works, creating We own the Ecosystem.DrGPCR.com Content, including but not limited to visual interfaces, interactive Note that your profile photo cannot include mature or offensive content.
- Visualizing GLP-1 & GIP Receptors in Islets and Brain | Dr. GPCR Ecosystem
Why this matters How receptor distribution in islets and brain circuits shapes incretin hormone drug
- Past Events by Dr. GPCR Ecosystem
Here, we celebrate the incredible moments that brought scientists, researchers, and GPCR enthusiasts
- Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem
arrestin biology, receptor complex pharmacology, and the angiotensin and chemokine receptor systems, including The development of NanoBRET - including live-cell ligand binding assays built on CRISPR-expressed receptors also has globally-recognized expertise in bioluminescence resonance energy transfer (BRET) technology, including
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
already failed — not because the biology is easier, but because new technology is rewarded most where the incumbents an opportunity to tackle the challenge of identifying novel functional antibodies targeting GPCRs by incorporating
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
Current lines of work include isoform-selective HSP90 inhibition as a strategy for widening the opioid The result: a six-hour feeding window for seven days increased morphine's antinociceptive efficacy in team focus on understanding how signal transduction cascades downstream of the opioid receptors work, including
- Dr. Richard Premont | Dr. GPCR Ecosystem
) and arrestins as GPCR regulators and as mediators of distinct signaling pathways through partners including In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
We focus on several aspects of metabolite-sensing GPCRs including signal transduction, intracellular Claudia suggested possible next steps, including researching review articles or articles to gain a higher
- Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem
framework does not address Adenosine receptors form both homodimers and heterodimers with other GPCRs, including The advice she offers to incoming PhD students centers not on technique but on disposition: stay curious
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
Other academic interests of his include studying pharmaceutical finance & healthcare administration and developing technologies that increase healthcare access. His non-academic interests include traveling, scouting out micro-breweries, and collecting beer cans.
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
Caron has received numerous awards including a Burroughs Wellcome Fund Career Award in the Biomedical
- Dr. Aurélien Rizk | Dr. GPCR Ecosystem
His academic background includes studies in mathematics, physics, and computer science at the French concluded with Yamina asking if Aurelien Rizk had a favorite GPCR to work on, though his response was not included Aurelien Rizk also mentioned the interdisciplinary nature of his company, which includes mathematics, They reminisced about previous meetings and events, including a GPCR retreat where Terry presented his
- Dr. Richard Premont | Dr. GPCR Ecosystem
) and arrestins as GPCR regulators and as mediators of distinct signaling pathways through partners including In our work, we utilize methods including structural biology and proteomics, molecular biology and biochemical
- Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Modern Research | Dr. GPCR Ecosystem
One day as they were catching up, Jacob shared his struggles of managing samples and an incredible amount
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
His current efforts bridge teaching in Toronto and ongoing research, including the development of an
- Dr. Marta Filizola | Dr. GPCR Ecosystem
structure, dynamics, and function of important classes of membrane proteins and prominent drug targets, including
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
pharmacology of the β₂-adrenergic receptor , a GPCR traditionally associated with bronchodilation but increasingly opportunities to design drugs that promote beneficial metabolic responses such as muscle growth and increased Later I became increasingly interested in skeletal muscle metabolism and how β₂-adrenergic signaling
- Yamina's Corner | Dr. GPCR Ecosystem
Enhance Client Project Delivery: Streamline workflows and improve scientific execution to increase client
- Who We Are | Dr. GPCR Ecosystem
Inclusion matters We welcome diverse voices, experiences, and expertise. Launched our podcast to share expert insights with the scientific community. 2021 2nd Annual Summit Increased Premium Members Include: ✔ Drug hunters at early-stage biotechs ✔ CRO leaders building assays and tools moving into translational work ✔ Teams preparing for fundraising or due diligence Expert Contributors Include Free Membership Includes: ✔ Free version of GPCR Weekly News - straight to your inbox!
- Trademark Policy | Dr. GPCR Ecosystem
GPCR Brand Features, including warranties of non-infringement. These include: - Dr. GPCR button including to ensure Publishers' compliance with these policies and to facilitate Dr. GPCR icon guidelines below, including color scheme, styling, and so forth. Dr. This includes online and offline advertising collateral such as: Merchandise featuring the Dr.
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
Slosky’s work has been recognized through several travel and research awards, including the William James Slosky is passionate about training the next generation of scientists and increasing diversity, equity , and inclusion in science.
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
training program at UCSD and has served as Editor or Senior Editor of numerous scientific journals, including
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
contributed to the identification of RAMP proteins, the GABA-B heterodimer, and ligands for orphan receptors including
- Dr. Michael Feigin | Dr. GPCR Ecosystem
Scientific Journey and Drug Discovery Challenges Mike shared significant moments in his scientific journey, including
- Brian Arey: Discovering Signaling Bias at the FSH Receptor | Dr. GPCR Ecosystem
That orientation shapes how he runs his team at BMS: a healthy skepticism toward established methods, including He then moved to work in the pharmaceutical industry where he has held positions of increasing responsibility
- Dr. David Sykes | Dr. GPCR Ecosystem
His current interests include the development of HTS fluorescence-based kinetic binding assays specifically
- Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem
academic group in Graz, she spent six and a half years at Novo Nordisk in early drug discovery, focused on incretin With comorbidities and aging populations driving drug discovery, the one-receptor-one-drug frame is increasingly eyeing industry or biotech 42:35 — On starting a GPCR company: why not too early 57:30 — Aha moments, including
























